Endogenous guanidino compounds as uremic neurotoxins

Kidney International, Supplement

Volumn 59, Issue 78, 2001, Pages

  De Deyn, P P ^a   D'Hooge, R ^a   Van Bogaert, P P ^a   Marescau, B ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Creatinine; Encephalopathy; Epilepsy; Guanidinosuccinic acid; Methylguanidine; NMDA receptors

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CONVULSANT AGENT; CREATININE; EXCITATORY AMINO ACID RECEPTOR; GUANIDINE; GUANIDINE DERIVATIVE; GUANIDINOSUCCINIC ACID; METHYLGUANIDINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTOXIN; UREMIC TOXIN; AMINO ACID RECEPTOR;

BLOOD LEVEL; BRAIN DISEASE; BRAIN LEVEL; CEREBROSPINAL FLUID LEVEL; COGNITIVE DEFECT; CONFERENCE PAPER; DEPOLARIZATION; EPILEPSY; EXCITABILITY; HUMAN; PRIORITY JOURNAL; UREMIA; ANIMAL; BIOLOGICAL MODEL; BRAIN; DRUG EFFECT; METABOLIC ENCEPHALOPATHY; METABOLISM; REVIEW; TISSUE DISTRIBUTION;

ANIMALS; BRAIN; BRAIN DISEASES, METABOLIC; CONVULSANTS; GUANIDINES; HUMANS; MODELS, NEUROLOGICAL; NEUROTOXINS; RECEPTORS, AMINO ACID; TISSUE DISTRIBUTION; UREMIA;

EID: 0035122206     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.59780077.x     Document Type: Conference Paper

References (41)

1. Clinical and pathophysiological aspects of neurological complications in renal failure
2. Uremic toxins
3. Uremic toxins
4. A reinvestigation of methylguanidine concentrations in sera from normal and uraemic subjects
5. Guanidinosuccinic acid in uremia
6. Guanidino compounds in serum and cerebrospinal fluid of non-dialyzed patients with renal insufficiency
7. Guanidino compound levels in brain regions of non-dialyzed uremic patients
8. Guanidino compounds in uraemic dialyzed patients
9. Serum guanidino compound levels and the influence of a single hemodialysis in uremic patients undergoing maintenance hemodialysis
10. Evidence that guanidines and some related compounds cause haemolysis in chronic uraemia
11. Pathophysiology of uremia
12. The presence and the toxicity of guanidinopropionic acid in uremia
13. Guanidinosuccinic acid in renal failure, experimental azotemia and inborn errors of the urea cycle
14. A new automated analytical method for guanidino compounds and their cerebrospinal fluid levels in uremia
15. Defective ADP-induced platelet factor 3 activation in uremia
16. Erythrocyte transketolase activity in dialyzed patients: A reversible metabolic lesion of uremia
17. Guanidinosuccinic acid: The "X" factor in uremic bleeding?
18. Methylguanidine in uremia
19. Uremia-like syndrome in dogs chronically intoxicated with methylguanidine and creatinine
20. Convulsive activity of methylguanidine in cat and rabbits
21. Biochemical and physiological studies on guanidino compounds induced convulsions
22. γ-guanidinobutyric acid as a convulsive substance
23. Biochemistry and neurotoxicology of guanidino compounds: History and recent advances
24. The effects of homoarginine on the EEG of rats
25. Inhibition of brain sodium-potassium ATPase in uremic rats
26. Effect of guanidino compounds on membrane fluidity of rat synaptosomes
27. Guanidino compounds in serum and urine of nondialysed patients with chronic renal insufficiency
28. Convulsive action and toxicity of uremic guanidino compounds: Behavioral assessment and relation to brain concentration in adult mice
29. The uremic guanidino compound guanidinosuccinic acid induces behavioral convulsions and concomitant epileptiform electrocorticographic discharges in mice
30. Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses on mouse neurons in cell culture
31. Uraemic guanidino compounds inhibit γ-amino-butyric acid-evoked whole-cell currents in mouse spinal cord neurones
32. The epileptogenic action of the taurine analogue guanidinoethane sulfonate may be caused by a blockade of GABA receptors
33. New antiepileptic drugs
34. Antiepileptic drugs: Pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds
35. N-methyl-D-aspartate receptors contribute to guanidinosuccinate-induced convulsions in mice
36. Multiple modes of NMDA receptor regulation by guanidines
37. N-methyl-D-aspartate receptor activation by guanidinosuccinate but not by methylguanidine: Behavioral and electrophysiological evidence
38. Excitatory amino acid receptors in the vertebrate central nervous system
39. Guanidinosuccinic acid inhibits excitatory synaptic transmission in CA 1 region of rat hippocampal slices
40. Epileptiform activity and hippocampal damage produced by intrahippocampal injection of guanidinosuccinic acid in rat
41. Anatomic organization and physiology of the limbic cortex